From professional translators, enterprises, web pages and freely available translation repositories.
recombinant human acid sphingomyelinase
recombinant human acid sphingomyelinase
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant human c1 - inhibitor
recombinant human c1-inhibitor
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
investigation of recombinant factor viii
note for guidance on the clinical investigation of recombinant factor viii and ix products released for consultation june 2000
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant human acid α- glucosidase
recombinant human acid α-glucosidase
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant human alpha- 1 antitrypsin
recombinant human alpha-1 antitrypsin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
myristolated- peptidyl - recombinant human cd59
myristolated-peptidyl- recombinant human cd59
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant human monoclonal antibody to hsp90
recombinant human monoclonal antibody to hsp90
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
gly2- recombinant human glucagon- like peptide
gly2-recombinant human glucagon-like peptide
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant inhibitor of human plasma kallikrein (dx- 88)
treatment of angioedema
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant coagulation factor viii products core spc for human plasma derived and
core spc for human plasma derived and recombinant coagulation factor viii products adopted june 2000
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant glycoprotein gp350 of epstein- barr virus (henogen 350)
recombinant glycoprotein gp350 of epstein-barr virus (henogen 350)
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
recombinant hepatitis b virus small surface antigen (hbsag) part a
antigen (hbsag)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
myristolated- peptidyl - recombinant scr1- 3 of human complement receptor type i
myristolated-peptidyl- recombinant scr1-3 of human complement
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
clinical evaluation of b-domain deleted recombinant factor viii in previously treated patients.
clinical evaluation of b-domain deleted recombinant factor viii in previously treated patients.
Last Update: 2008-03-04
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
live suspension v hvt013- 69 recombinant virus, κατ ’ ελάχιστον 3, 6 log 10 pfu
vhvt013-69 diluent for injection. and recombinant virus, at least 3.6 log10 pfu
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
west nile recombinant canarypox virus (ιός ευλογιάς καναρινιού ανασυνδυασμένος με ιό Δυτικού Νείλου) (vcp2017) ......................................................................................
west nile recombinant canarypox virus (vcp2017) .......................................
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Τίτλος εγγράφου requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
25 µg filamentous haemagglutinin, adsorbed 25 µg, pertactin, adsorbed 8 µ g recombinant hepatitis b surface antigen (s protein), adsorbed 10 µg inactivated type 1 poliovirus 40 du inactivated type 2 poliovirus 8 du inactivated type 3 poliovirus 32 du
40iu pertussis toxoid, adsorbed 25 µg filamentous haemagglutinin, adsorbed 25 µg, pertactin, adsorbed 8 µg recombinant hepatitis b surface antigen (s protein), adsorbed 10 µg inactivated type 1 poliovirus 40 du inactivated type 2 poliovirus 8 du inactivated type 3 poliovirus 32 du
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
